Is Novolog (Pharm-Up 1966) stock a buy?

Yes, Novolog (Pharm-Up 1966) pays dividends. Last time was Thursday 12th of September 2024 where the investors holding the stock on Tuesday 3rd of September 2024 were paid ILA2.93687 per share. Over the last 10 times between 2018 and 2024, Novolog (Pharm-Up 1966) has paid ILA31.04652 with an average of ILA3.1 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Novolog (Pharm-Up 1966) 10 years ago, but if you had invested on Sunday 8th of September 2019 when the price was ILA173.90, you would have made a loss of ILA-12.60 per share or -7.25%

Yes, the average daily trading liquidity for Novolog (Pharm-Up 1966) is ILA169 285 thousand. You should therefore be able to get in and out of your positions relatively fast.

Novolog (Pharm-Up 1966) has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.73, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Novolog (Pharm-Up 1966) to be low [0.3 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.